Induction of cell-associated chemokines after endotoxin administration to healthy humans. 2001

D P Olszyna, and E De Jonge, and P E Dekkers, and S J van Deventer, and T van der Poll
Department of Experimental Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Erythrocytes express the Duffy antigen receptor for chemokines. Endotoxin injection into humans induced high levels of interleukin-8 (IL-8), growth-related oncogene alpha, and monocyte chemoattractant protein 1 in circulating erythrocytes. IL-8 was also recovered from mononuclear and polymorphonuclear cells. Cell-associated chemokines may more accurately reflect their production than plasma concentrations.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D001773 Blood Cells The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM. Blood Corpuscles,Blood Cell,Blood Corpuscle,Cell, Blood,Cells, Blood,Corpuscle, Blood,Corpuscles, Blood
D002630 Chemotactic Factors Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult. Chemoattractant,Chemotactic Factor,Chemotaxin,Chemotaxins,Cytotaxinogens,Cytotaxins,Macrophage Chemotactic Factor,Chemoattractants,Chemotactic Factors, Macrophage,Macrophage Chemotactic Factors,Chemotactic Factor, Macrophage,Factor, Chemotactic,Factor, Macrophage Chemotactic
D006133 Growth Substances Signal molecules that are involved in the control of cell growth and differentiation. Mitogens, Endogenous,Endogenous Mitogens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016209 Interleukin-8 A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells. CXCL8 Chemokine,Chemokine CXCL8,Chemotactic Factor, Macrophage-Derived,Chemotactic Factor, Neutrophil, Monocyte-Derived,IL-8,Neutrophil-Activating Peptide, Lymphocyte-Derived,Neutrophil-Activating Peptide, Monocyte-Derived,AMCF-I,Alveolar Macrophage Chemotactic Factor-I,Anionic Neutrophil-Activating Peptide,Chemokines, CXCL8,Chemotactic Factor, Neutrophil,Granulocyte Chemotactic Peptide-Interleukin-8,IL8,Monocyte-Derived Neutrophil Chemotactic Factor,Neutrophil Activation Factor,Alveolar Macrophage Chemotactic Factor I,Anionic Neutrophil Activating Peptide,CXCL8 Chemokines,CXCL8, Chemokine,Chemokine, CXCL8,Chemotactic Factor, Macrophage Derived,Chemotactic Peptide-Interleukin-8, Granulocyte,Granulocyte Chemotactic Peptide Interleukin 8,Interleukin 8,Lymphocyte-Derived Neutrophil-Activating Peptide,Macrophage-Derived Chemotactic Factor,Monocyte-Derived Neutrophil-Activating Peptide,Neutrophil Activating Peptide, Lymphocyte Derived,Neutrophil Activating Peptide, Monocyte Derived,Neutrophil Chemotactic Factor,Neutrophil-Activating Peptide, Anionic,Peptide, Anionic Neutrophil-Activating
D054360 Chemokine CXCL1 A CXC chemokine with specificity for CXCR2 RECEPTORS. It has growth factor activities and is implicated as a oncogenic factor in several tumor types. CXCL1 Chemokine,Chemokine (C-X-C Motif) Ligand 1,GROalpha Protein,Gro-alpha Protein,Growth-Related Oncogene alpha Protein,MGSA-alpha Chemokine,Melanoma Growth Stimulatory Activity, alpha Protein,Neutrophil-Activating Protein 3,CXCL1, Chemokine,Chemokine, CXCL1,Chemokine, MGSA-alpha,Gro alpha Protein,Growth Related Oncogene alpha Protein,MGSA alpha Chemokine,Neutrophil Activating Protein 3
D054407 Chemokine CCL4 A CC chemokine with specificity for CCR5 RECEPTORS. It is a chemoattractant for NK CELLS; MONOCYTES and a variety of other immune cells. This chemokine is encoded by multiple genes. CCL4 Chemokine,CCL4L1 Chemokine,CCL4L2 Chemokine,Chemokine CCL4L1,Chemokine CCL4L2,MIP-1beta,Macrophage Inflammatory Protein 1-beta,Macrophage Inflammatory Protein-1beta2,CCL4, Chemokine,CCL4L1, Chemokine,CCL4L2, Chemokine,Chemokine, CCL4,Chemokine, CCL4L1,Chemokine, CCL4L2,Inflammatory Protein-1beta2, Macrophage,MIP 1beta,Macrophage Inflammatory Protein 1 beta,Macrophage Inflammatory Protein 1beta2
D018925 Chemokines Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; (CHEMOKINES, C); CC; (CHEMOKINES, CC); and CXC; (CHEMOKINES, CXC); according to variations in a shared cysteine motif. Chemokine,Chemotactic Cytokine,Chemotactic Cytokines,Cytokines, Chemotactic,Intercrine,Intercrines,Cytokine, Chemotactic

Related Publications

D P Olszyna, and E De Jonge, and P E Dekkers, and S J van Deventer, and T van der Poll
December 2002, The Journal of infectious diseases,
D P Olszyna, and E De Jonge, and P E Dekkers, and S J van Deventer, and T van der Poll
June 2000, The Journal of infectious diseases,
D P Olszyna, and E De Jonge, and P E Dekkers, and S J van Deventer, and T van der Poll
February 1994, The Journal of infectious diseases,
D P Olszyna, and E De Jonge, and P E Dekkers, and S J van Deventer, and T van der Poll
December 2004, Intensive care medicine,
D P Olszyna, and E De Jonge, and P E Dekkers, and S J van Deventer, and T van der Poll
February 1991, Current eye research,
D P Olszyna, and E De Jonge, and P E Dekkers, and S J van Deventer, and T van der Poll
September 1991, The Journal of infectious diseases,
D P Olszyna, and E De Jonge, and P E Dekkers, and S J van Deventer, and T van der Poll
November 1990, The American journal of physiology,
D P Olszyna, and E De Jonge, and P E Dekkers, and S J van Deventer, and T van der Poll
September 2013, Psychoneuroendocrinology,
D P Olszyna, and E De Jonge, and P E Dekkers, and S J van Deventer, and T van der Poll
August 2018, Clinical pharmacology in drug development,
D P Olszyna, and E De Jonge, and P E Dekkers, and S J van Deventer, and T van der Poll
June 1993, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!